Management of Interstitial Lung Diseases: A Consensus Statement of the Indian Chest Society and National College of Chest Physicians (India)-Reference-Cited by-同舟云学术

Management of Interstitial Lung Diseases: A Consensus Statement of the Indian Chest Society and National College of Chest Physicians (India)

Published:2022-11-07 Issue:2 Volume:62 Page:73-98
ISSN:0377-9343
Container-title:The Indian Journal of Chest Diseases and Allied Sciences
language:en
Short-container-title:

Author:

Singh Harpreet,Jankharia Bhavin,Singh Sheetu,Dhar Raja,Gothi Dipti,Behera Digambar,Hadda Vijay,Talwar Deepak,Pilania Khushboo,Desai Unnati,Singh Abhijeet,Sharma Bharat Bhushan,Bairwa Mohan,Joshi Jyotsna M.,Sharma Ambika,Ahluwalia Bineet,Mangal Daya K.,Jain Nirmal K.,Koul Parvaiz,Luhadia Shanti Kumar,Swarnkar Rajesh,Gaur Shailender Nath,Ghoshal Aloke G.,Nene Amita,Jindal Arpita,Ravindran Chetambath,Choudhary Dhruv,Christopher D.J.,Khilnani Gopi Chand,Samaria Jai Kumar

Publisher

Jaypee Brothers Medical Publishing

Subject

General Medicine

Link

https://www.ijcdas.com/doi/pdf/10.5005/ijcdas-62-2-73

Reference145 articles.

1. 1. ATS Statement. Am J Respir Crit Care Med 2002;166:111–7.

2. 2. Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med 2017;196:1463–72.

3. 3. Collard HR, King TE, Jr., Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538–42.

4. 4. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650–6.

5. 5. SOCIETY BT, COMMITTEE SOC. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Thorax 1999;54(Suppl. 1):S1–S28.